Cargando…

CD133 expression predicts lung metastasis and poor prognosis in osteosarcoma patients: A clinical and experimental study

Identifying prognostic factors for osteosarcoma (OS) aids in the selection of patients who require more aggressive management. CD133 has been found to be a prognostic factor of certain tumor types. However, the association between CD133 expression and the prognosis of OS remains unknown. In this stu...

Descripción completa

Detalles Bibliográficos
Autores principales:	HE, AINA, QI, WEIXIANG, HUANG, YUJING, FENG, TAO, CHEN, JIE, SUN, YUANJUE, SHEN, ZAN, YAO, YANG
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2012
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3503795/ https://www.ncbi.nlm.nih.gov/pubmed/23181114 http://dx.doi.org/10.3892/etm.2012.603

Ejemplares similares

Prognostic value of inflammation-based scores in patients with osteosarcoma
por: Liu, Bangjian, et al.
Publicado: (2016)

The Prognostic Role of Ezrin Immunoexpression in Osteosarcoma: A Meta-Analysis of Published Data
por: Li, Hongtao, et al.
Publicado: (2013)

The Plasma Concentration of D-Dimer is Associated with Neoadjuvant-Chemotherapy Efficacy and the Prognosis in Osteosarcoma
por: Huang, Yujing, et al.
Publicado: (2021)

The prognostic value of D-dimer levels in metastatic osteosarcoma patients treated with second-line chemotherapy
por: Huang, Yujing, et al.
Publicado: (2016)

Lack of association between platelet indices and disease stage in osteosarcoma at diagnosis
por: Li, Hongtao, et al.
Publicado: (2017)

Overexpression of Epcam and CD133 Correlates with Poor Prognosis in Dual-phenotype Hepatocellular Carcinoma
por: Zhang, Jie, et al.
Publicado: (2020)

Impact of chemotherapy cycles and intervals on outcomes of nonspinal Ewing sarcoma in adults: a real-world experience
por: Zhang, Jianjun, et al.
Publicado: (2019)

Expression of CD133 is associated with poor prognosis in stage II colorectal carcinoma
por: Park, Youn Young, et al.
Publicado: (2019)

Expression of CD133 in the cytoplasm is associated with cancer progression and poor prognosis in gastric cancer
por: Hashimoto, Kousuke, et al.
Publicado: (2013)

Augmented CD133 expression in distal margin correlates with poor prognosis in colorectal cancer
por: Pradhan, Tapas, et al.
Publicado: (2019)

Nestin expression in osteosarcomas and derivation of nestin/CD133 positive osteosarcoma cell lines
por: Veselska, Renata, et al.
Publicado: (2008)

Overexpression of Notch3 is associated with metastasis and poor prognosis in osteosarcoma patients
por: Tang, Xue-Feng, et al.
Publicado: (2019)

Calponin 3 is associated with poor prognosis and regulates proliferation and metastasis in osteosarcoma
por: Dai, Fei, et al.
Publicado: (2020)

CD133(+)CXCR4(+ )colon cancer cells exhibit metastatic potential and predict poor prognosis of patients
por: Zhang, Shan-shan, et al.
Publicado: (2012)

High CD133 Expression in the Nucleus and Cytoplasm Predicts Poor Prognosis in Non-Small Cell Lung Cancer
por: Huang, Minjie, et al.
Publicado: (2015)

Increased DEF6 expression is correlated with metastasis and poor prognosis in human osteosarcoma
por: Zhang, Qiao, et al.
Publicado: (2020)

MCAM is associated with metastasis and poor prognosis in osteosarcoma by modulating tumor cell migration
por: Du, Xiaotian, et al.
Publicado: (2021)

Higher percentage of CD133(+ )cells is associated with poor prognosis in colon carcinoma patients with stage IIIB
por: Li, Chun-Yan, et al.
Publicado: (2009)

CD133 expression in cancer cells predicts poor prognosis of non-mucin producing intrahepatic cholangiocarcinoma
por: Cai, Xiaobo, et al.
Publicado: (2018)

Dysregulated m6A-Related Regulators Are Associated With Tumor Metastasis and Poor Prognosis in Osteosarcoma
por: Li, Jianhao, et al.
Publicado: (2020)

Poly(lactic-co-glycolic acid) nanoparticles conjugated with CD133 aptamers for targeted salinomycin delivery to CD133(+) osteosarcoma cancer stem cells
por: Ni, Miaozhong, et al.
Publicado: (2015)

TUFT1 Promotes Osteosarcoma Cell Proliferation and Predicts Poor Prognosis in Osteosarcoma Patients
por: Yu, Yao-Ping, et al.
Publicado: (2018)

Clinical Significance of Cancer Stem Cell Markers CD133 and CXCR4 in Osteosarcomas
por: Mardani, Azam, et al.
Publicado: (2020)

YY1 overexpression is associated with poor prognosis and metastasis-free survival in patients suffering osteosarcoma
por: Nigris, Filomena de, et al.
Publicado: (2011)

PLA2G16 Expression in Human Osteosarcoma Is Associated with Pulmonary Metastasis and Poor Prognosis
por: Liang, Shoulei, et al.
Publicado: (2015)

Promoter hypermethylation of CD133/PROM1 is an independent poor prognosis factor for head and neck squamous cell carcinoma
por: Hu, Zele, et al.
Publicado: (2020)

Human osteosarcoma CD49f(−)CD133(+) cells: impaired in osteogenic fate while gain of tumorigenicity
por: Ying, Meidan, et al.
Publicado: (2012)

Fascin-1 enhances experimental osteosarcoma tumor formation and metastasis and is related to poor patient outcome
por: Arlt, Matthias J., et al.
Publicado: (2019)

CD146 promotes metastasis and predicts poor prognosis of hepatocellular carcinoma
por: Jiang, Guoqing, et al.
Publicado: (2016)

Single-cell RNA landscape of intratumoral heterogeneity and immunosuppressive microenvironment in advanced osteosarcoma
por: Zhou, Yan, et al.
Publicado: (2020)

CD133 expression correlates with clinicopathologic features and poor prognosis of colorectal cancer patients: An updated meta-analysis of 37 studies
por: Huang, Rongyong, et al.
Publicado: (2018)

High serum alkaline phosphatase cooperating with MMP-9 predicts metastasis and poor prognosis in patients with primary osteosarcoma in Southern China
por: Han, Ju, et al.
Publicado: (2012)

CD133: a potential indicator for differentiation and prognosis of human cholangiocarcinoma
por: Fan, Linni, et al.
Publicado: (2011)

Author Correction: Single-cell RNA landscape of intratumoral heterogeneity and immunosuppressive microenvironment in advanced osteosarcoma
por: Zhou, Yan, et al.
Publicado: (2021)

Overexpression of p62 is associated with poor prognosis and aggressive phenotypes in osteosarcoma
por: Lu, Yao, et al.
Publicado: (2018)

CD133 expression correlates with clinicopathologic features and poor prognosis of colorectal cancer patients: An updated meta-analysis of 37 studies: Erratum
Publicado: (2018)

Oxytetracycline have the therapeutic efficiency in CD133(+) HCC population through suppression CD133 expression by decreasing of protein stability of CD133
por: Song, Yeonhwa, et al.
Publicado: (2018)

CD133 and Ki-67 expression is associated with gastrointestinal stromal tumor prognosis
por: LU, CANRONG, et al.
Publicado: (2013)

An Overview of CD133 as a Functional Unit of Prognosis and Treatment Resistance in Glioblastoma
por: Joyce, Thomas, et al.
Publicado: (2023)

CD73 is associated with poor prognosis in HNSCC
por: Ren, Zhen-Hu, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_p5pptf94jr8m5uknbi079ggrde